Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 243-250 , April 2010

Lipid droplets in inflammation and cancer

  • Patricia T. Bozza

      Affiliations

    • Laboratório de Imunofarmacologia, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Av. Brasil, 4365 Manguinhos, Rio de Janeiro, RJ 21045-900, Brazil
    • Corresponding Author InformationCorresponding author. Tel.: +552125621767.
    • ,
  • João P.B. Viola

      Affiliations

    • Division of Cellular Biology, National Cancer Institute, Rio de Janeiro, Brazil

References 

  1. Bozza PT, Magalhaes KG, Weller PF. Leukocyte lipid bodies—biogenesis and functions in inflammation. Biochim. Biophys. Acta. 2009;1791:540–551
  2. Martin S, Parton RG. Lipid droplets: a unified view of a dynamic organelle. Nat. Rev. Mol. Cell. Biol. 2006;7:373–378
  3. Murphy DJ. The biogenesis and functions of lipid bodies in animals, plants and microorganisms. Prog. Lipid Res. 2001;40:325–438
  4. Robenek MJ, Severs NJ, Schlattmann K, Plenz G, Zimmer KP, Troyer D, et al. Lipids partition caveolin-1 from ER membranes into lipid droplets: updating the model of lipid droplet biogenesis. FASEB J. 2004;18:866–868
  5. Brown DA. Lipid droplets: proteins floating on a pool of fat. Curr. Biol. 2001;11:R446–R449
  6. Wan HC, Melo RC, Jin Z, Dvorak AM, Weller PF. Roles and origins of leukocyte lipid bodies: proteomic and ultrastructural studies. FASEB J. 2007;21:167–178
  7. Ploegh HL. A lipid-based model for the creation of an escape hatch from the endoplasmic reticulum. Nature. 2007;448:435–438
  8. Guo Y, Cordes KR, Farese RV, Walther TC. Lipid droplets at a glance. J. Cell. Sci. 2009;122:749–752
  9. Dvorak AM, Morgan E, Schleimer RP, Ryeom SW, Lichtenstein LM, Weller PF. Ultrastructural immunogold localization of prostaglandin endoperoxide synthase (cyclooxygenase) to non-membrane-bound cytoplasmic lipid bodies in human lung mast cells, alveolar macrophages, type II pneumocytes, and neutrophils. J. Histochem. Cytochem. 1992;40:759–769
  10. Dvorak AM, Morgan ES, Tzizik DM, Weller PF. Prostaglandin endoperoxide synthase (cyclooxygenase): ultrastructural localization to nonmembrane-bound cytoplasmic lipid bodies in human eosinophils and 3T3 fibroblasts. Int. Arch. Allergy Immunol. 1994;105:245–250
  11. Dvorak AM, Weller PF, Harvey VS, Morgan ES, Dvorak HF. Ultrastructural localization of prostaglandin endoperoxide synthase (cyclooxygenase) to isolated, purified fractions of guinea pig peritoneal macrophage and line 10 hepatocarcinoma cell lipid bodies. Int. Arch. Allergy Immunol. 1993;101:136–142
  12. Bozza PT, Yu W, Penrose JF, Morgan ES, Dvorak AM, Weller PF. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation. J. Exp. Med. 1997;186:909–920
  13. Arend A, Masso R, Masso M, Selstam G. Electron microscope immunocytochemical localization of cyclooxygenase-1 and -2 in pseudopregnant rat corpus luteum during luteolysis. Prostaglandins Other Lipid Mediat. 2004;74:1–10
  14. Meadows JW, Pitzer B, Brockman DE, Myatt L. Expression and localization of adipophilin and perilipin in human fetal membranes: association with lipid bodies and enzymes involved in prostaglandin synthesis. J. Clin. Endocrinol. Metab. 2005;90:2344–2350
  15. Thore CR, Beasley TC, Busija DW. In vitro and in vivo localization of prostaglandin H synthase in fetal sheep neurons. Neurosci. Lett. 1998;242:29–32
  16. Robenek H, Robenek MJ, Troyer D. PAT family proteins pervade lipid droplet cores. J. Lipid Res. 2005;46:1331–1338
  17. Dvorak AM. Mast cell secretory granules and lipid bodies contain the necessary machinery important for the in situ synthesis of proteins. Chem. Immunol. Allergy. 2005;85:252–315
  18. Dvorak AM, Morgan ES, Weller PF. RNA is closely associated with human mast cell lipid bodies. Histol. Histopathol. 2003;18:943–968
  19. Bozza PT, Payne JL, Goulet JL, Weller PF. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids. J. Exp. Med. 1996;183:1515–1525
  20. Weller PF, Ryeom SW, Picard ST, Ackerman SJ, Dvorak AM. Cytoplasmic lipid bodies of neutrophils: formation induced by cis-unsaturated fatty acids and mediated by protein kinase C. J. Cell. Biol. 1991;113:137–146
  21. Moreira LS, Piva B, Gentile LB, Mesquita-Santos FP, D'Avila H, Maya-Monteiro CM, et al. Cytosolic phospholipase A2-driven PGE2 synthesis within unsaturated fatty acids-induced lipid bodies of epithelial cells. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2009;1791:156–165
  22. Bozza PT, Weller PF. Arachidonyl trifluoromethyl ketone induces lipid body formation in leukocytes. Prostaglandins Leukot. Essent. Fatty Acids. 2001;64:227–230
  23. Ross R. Cell biology of atherosclerosis. Annu. Rev. Physiol. 1995;57:791–804
  24. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat. Med. 2002;8:1235–1242
  25. Schmitz G, Grandl M. Lipid homeostasis in macrophages—implications for atherosclerosis. Rev. Physiol. Biochem. Pharmacol. 2008;160:93–125
  26. Bozza PT, Yu W, Cassara J, Weller PF. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects. J. Leukoc. Biol. 1998;64:563–569
  27. Bandeira-Melo C, Phoofolo M, Weller PF. Extranuclear lipid bodies, elicited by CCR3-mediated signaling pathways, are the sites of chemokine-enhanced leukotriene C4 production in eosinophils and basophils. J. Biol. Chem. 2001;276:22779–22787
  28. Maya-Monteiro CM, Almeida PE, D'Avila H, Martins AS, Rezende AP, Castro-Faria-Neto H, et al. Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 2008;283:2203–2210
  29. Vieira-de-Abreu A, Assis EF, Gomes GS, Castro-Faria-Neto HC, Weller PF, Bandeira-Melo C, et al. Allergic challenge-elicited lipid bodies compartmentalize in vivo leukotriene C4 synthesis within eosinophils. Am. J. Respir. Cell. Mol. Biol. 2005;33:254–261
  30. Pacheco P, Vieira-de-Abreu A, Gomes RN, Barbosa-Lima G, Wermelinger LB, Maya-Monteiro CM, et al. Monocyte chemoattractant protein-1/CC chemokine ligand 2 controls microtubule-driven biogenesis and leukotriene B4-synthesizing function of macrophage lipid bodies elicited by innate immune response. J. Immunol. 2007;179:8500–8508
  31. de Assis EF, Silva AR, Caiado LF, Marathe GK, Zimmerman GA, Prescott SM, et al. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. J. Immunol. 2003;171:2090–2098
  32. Mesquita-Santos FP, Vieira-de-Abreu A, Calheiros AS, Figueiredo IH, Castro-Faria-Neto HC, Weller PF, et al. Cutting edge: prostaglandin D2 enhances leukotriene C4 synthesis by eosinophils during allergic inflammation: synergistic in vivo role of endogenous eotaxin. J. Immunol. 2006;176:1326–1330
  33. Bandeira-Melo C, Sugiyama K, Woods LJ, Phoofolo M, Center DM, Cruikshank WW, et al. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling. J. Immunol. 2002;168:4756–4763
  34. Bartemes KR, McKinney S, Gleich GJ, Kita H. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG. J. Immunol. 1999;162:2982–2989
  35. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc. Natl. Acad. Sci. USA. 1979;76:333–337
  36. de Villiers WJ, Smart EJ. Macrophage scavenger receptors and foam cell formation. J. Leukoc. Biol. 1999;66:740–746
  37. Rahaman SO, Lennon DJ, Febbraio M, Podrez EA, Hazen SL, Silverstein RL. A CD36-dependent signaling cascade is necessary for macrophage foam cell formation. Cell. Metab. 2006;4:211–221
  38. Hodgkinson CP, Laxton RC, Patel K, Ye S. Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2008;28:2275–2281
  39. Zhao Z, de Beer MC, Cai L, Asmis R, de Beer FC, de Villiers WJ, et al. Low-density lipoprotein from apolipoprotein E-deficient mice induces macrophage lipid accumulation in a CD36 and scavenger receptor class A-dependent manner. Arterioscler. Thromb. Vasc. Biol. 2005;25:168–173
  40. Buechler C, Ritter M, Duong CQ, Orso E, Kapinsky M, Schmitz G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim. Biophys. Acta. 2001;1532:97–104
  41. Kapinsky M, Torzewski M, Buchler C, Duong CQ, Rothe G, Schmitz G. Enzymatically degraded LDL preferentially binds to CD14(high) CD16(+) monocytes and induces foam cell formation mediated only in part by the class B scavenger-receptor CD36. Arterioscler. Thromb. Vasc. Biol. 2001;21:1004–1010
  42. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983;52:223–261
  43. Silva AR, de Assis EF, Caiado LF, Marathe GK, Bozza MT, McIntyre TM, et al. Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoprotein. J. Immunol. 2002;168:4112–4120
  44. Chen JS, Greenberg AS, Tseng YZ, Wang SM. Possible involvement of protein kinase C in the induction of adipose differentiation-related protein by Sterol ester in RAW 264.7 macrophages. J. Cell. Biochem. 2001;83:187–199
  45. Leonarduzzi G, Chiarpotto E, Biasi F, Poli G. 4-Hydroxynonenal and cholesterol oxidation products in atherosclerosis. Mol. Nutr. Food Res. 2005;49:1044–1049
  46. Boullier A, Friedman P, Harkewicz R, Hartvigsen K, Green SR, Almazan F, et al. Phosphocholine as a pattern recognition ligand for CD36. J. Lipid Res. 2005;46:969–976
  47. Silva AR, Pacheco P, Vieira-de-Abreu A, Maya-Monteiro CM, D'Alegria B, Magalhaes KG, et al. Lipid bodies in oxidized LDL-induced foam cells are leukotriene-synthesizing organelles: a MCP-1/CCL2 regulated phenomenon. Biochim. Biophys. Acta. 2009;1791:1066–1075
  48. Dvorak AM. Biochemical contents of granules and lipid bodies—two distinctive organelles found in basophils and mast cells. Basophil and Mast Cell Degranulation and Recovery. New York: Plenum Press; 1991;
  49. Franke WW, Hergt M, Grund C. Rearrangement of the vimentin cytoskeleton during adipose conversion: formation of an intermediate filament cage around lipid globules. Cell. 1987;49:131–141
  50. Mermelstein CS, Guma FC, Mello TG, Fortuna VA, Guaragna RM, Costa ML, et al. Induction of the lipocyte phenotype in murine hepatic stellate cells: reorganisation of the actin cytoskeleton. Cell. Tissue Res. 2001;306:75–83
  51. Pol A, Martin S, Fernandez MA, Ferguson C, Carozzi A, Luetterforst R, et al. Dynamic and regulated association of caveolin with lipid bodies: modulation of lipid body motility and function by a dominant negative mutant. Mol. Biol. Cell. 2004;15:99–110
  52. Bostrom P, Rutberg M, Ericsson J, Holmdahl P, Andersson L, Frohman MA, et al. Cytosolic lipid droplets increase in size by microtubule-dependent complex formation. Arterioscler. Thromb. Vasc. Biol. 2005;25:1945–1951
  53. Xu W, Yu L, Zhou W, Luo M. Resistin increases lipid accumulation and CD36 expression in human macrophages. Biochem. Biophys. Res. Commun. 2006;351:376–382
  54. Maya-Monteiro CM, Bozza PT. Leptin and mTOR: partners in metabolism and inflammation. Cell. Cycle. 2008;7:1713–1717
  55. Larigauderie G, Furman C, Jaye M, Lasselin C, Copin C, Fruchart JC, et al. Adipophilin enhances lipid accumulation and prevents lipid efflux from THP-1 macrophages: potential role in atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2004;24:504–510
  56. Wang SM, Hwang RD, Greenberg AS, Yeo HL. Temporal and spatial assembly of lipid droplet-associated proteins in 3T3-L1 preadipocytes. Histochem. Cell. Biol. 2003;120:285–292
  57. Gross DN, Miyoshi H, Hosaka T, Zhang HH, Pino EC, Souza S, et al. Dynamics of lipid droplet-associated proteins during hormonally stimulated lipolysis in engineered adipocytes: stabilization and lipid droplet binding of adipocyte differentiation-related protein/adipophilin. Mol. Endocrinol. 2006;20:459–466
  58. Chung S, Brown JM, Sandberg MB, McIntosh M. Trans-10,cis-12 CLA increases adipocyte lipolysis and alters lipid droplet-associated proteins: role of mTOR and ERK signaling. J. Lipid Res. 2005;46:885–895
  59. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science. 2001;294:1866–1870
  60. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K, Wahli W. Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA. 1993;90:2160–2164
  61. Gearing KL, Gottlicher M, Teboul M, Widmark E, Gustafsson JA. Interaction of the peroxisome-proliferator-activated receptor and retinoid X receptor. Proc. Natl. Acad. Sci. USA. 1993;90:1440–1444
  62. Nagy L, Tontonoz P, Alvarez JG, Chen H, Evans RM. Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma. Cell. 1998;93:229–240
  63. Tontonoz P, Nagy L, Alvarez JG, Thomazy VA, Evans RM. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 1998;93:241–252
  64. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 1998;391:79–82
  65. Chawla A, Barak Y, Nagy L, Liao D, Tontonoz P, Evans RM. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nat. Med. 2001;7:48–52
  66. Almeida PE, Silva AR, Maya-Monteiro CM, Torocsik D, Avila HD, Dezso B, et al. Mycobacterium bovis Bacillus Calmette-Guerin infection induces TLR2-dependent peroxisome proliferator-activated receptor {gamma} expression and activation: functions in inflammation, lipid metabolism, and pathogenesis. J. Immunol. 2009;183:1337–1345
  67. D'Avila H, Roque NR, Cardoso RM, Castro-Faria-Neto HC, Melo RC, Bozza PT. Neutrophils recruited to the site of mycobacterium bovis BCG infection undergo apoptosis and modulate lipid body biogenesis and prostaglandin E production by macrophages. Cell. Microbiol. 2008;10:2589–2604
  68. Samsa MM, Mondotte JA, Iglesias NG, Assuncao-Miranda I, Barbosa-Lima G, Da Poian AT, et al. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS. Pathog. 2009;5:e1000632
  69. Accioly MT, Pacheco P, Maya-Monteiro CM, Carrossini N, Robbs BK, Oliveira SS, et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells. Cancer Res. 2008;68:1732–1740
  70. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr. Opin. Clin. Nutr. Metab. Care. 2006;9:358–365
  71. Kuhajda FP. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006;66:5977–5980
  72. Than NG, Sumegi B, Bellyei S, Berki T, Szekeres G, Janaky T, et al. Lipid droplet and milk lipid globule membrane associated placental protein 17b (PP17b) is involved in apoptotic and differentiation processes of human epithelial cervical carcinoma cells. Eur. J. Biochem. 2003;270:1176–1188
  73. Opstad KS, Bell BA, Griffiths JR, Howe FA. An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRSand histological analysis. NMR Biomed. 2008;21:677–685
  74. Hirano T, Morii H, Nakazawa K, Murakami D, Yamashita A, Asahi J, et al. Enhancement of adipogenesis induction by conditioned media obtained from cancer cells. Cancer Lett. 2008;268:286–294
  75. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol. 2003;24:639–645
  76. Wymann MP, Schneiter R. Lipid signalling in disease. Nat. Rev. Mol. Cell. Biol. 2008;9:162–176
  77. Dvorak AM, Dvorak HF, Peters SP, Shulman ES, MacGlashan DW, Pyne K, et al. Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. J. Immunol. 1983;131:2965–2976
  78. Weller PF, Ackerman SJ, Nicholson-Weller A, Dvorak AM. Cytoplasmic lipid bodies of human neutrophilic leukocytes. Am. J. Pathol. 1989;135:947–959
  79. Weller PF, Monahan-Earley RA, Dvorak HF, Dvorak AM. Cytoplasmic lipid bodies of human eosinophils. Subcellular isolation and analysis of arachidonate incorporation. Am. J. Pathol. 1991;138:141–148
  80. Plotkowski MC, Brandao BA, de Assis MC, Feliciano LF, Raymond B, Freitas C, et al. Lipid body mobilization in the ExoU-induced release of inflammatory mediators by airway epithelial cells. Microb. Pathog. 2008;45:30–37
  81. Six DA, Dennis EA. The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim. Biophys. Acta. 2000;1488:1–19
  82. Ghosh M, Tucker DE, Burchett SA, Leslie CC. Properties of the Group IV phospholipase A2 family. Prog. Lipid Res. 2006;45:487–510
  83. Yu W, Bozza PT, Tzizik DM, Gray JP, Cassara J, Dvorak AM, et al. Co-compartmentalization of MAP kinases and cytosolic phospholipase A2 at cytoplasmic arachidonate-rich lipid bodies. Am. J. Pathol. 1998;152:759–769
  84. Wooten RE, Willingham MC, Daniel LW, Leslie CC, Rogers LC, Sergeant S, et al. Novel translocation responses of cytosolic phospholipase A(2)alpha fluorescent proteins. Biochim. Biophys. Acta. 2008;1783:1544–1550
  85. Pacheco P, Bozza FA, Gomes RN, Bozza M, Weller PF, Castro-Faria-Neto HC, et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 2002;169:6498–6506
  86. D'Avila H, Melo RC, Parreira GG, Werneck-Barroso E, Castro-Faria-Neto HC, Bozza PT. Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo. J. Immunol. 2006;176:3087–3097
  87. Bozza PT, Payne JL, Morham SG, Langenbach R, Smithies O, Weller PF. Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin. Proc. Natl. Acad. Sci. USA. 1996;93:11091–11096
  88. Weller PF, Bozza PT, Yu W, Dvorak AM. Cytoplasmic lipid bodies in eosinophils: central roles in eicosanoid generation. Int. Arch. Allergy Immunol. 1999;118:450–452
  89. Melo RC, D'Avila H, Fabrino DL, Almeida PE, Bozza PT. Macrophage lipid body induction by Chagas disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell. 2003;35:59–67
  90. C. Bandeira Melo, P.F. Weller, P.T. Bozza, Eicosacell—an immunofluorescent-based assay to localize newly synthesized eicosanoid lipid mediators at intracellular sites methods, Methods Mol. Biol., in press.
  91. Bandeira-Melo C, Bozza PT, Weller PF. The cellular biology of eosinophil eicosanoid formation and function. J. Allergy Clin. Immunol. 2002;109:393–400
  92. Seachord CL, VandeVoort CA, Duffy DM. Adipose differentiation-related protein: a gonadotropin- and prostaglandin-regulated protein in primate periovulatory follicles. Biol. Reprod. 2005;72:1305–1314
  93. Meadows JW, Eis AL, Brockman DE, Myatt L. Expression and localization of prostaglandin E synthase isoforms in human fetal membranes in term and preterm labor. J. Clin. Endocrinol. Metab. 2003;88:433–439
  94. Scarfo LM, Weller PF, Farber HW. Induction of endothelial cell cytoplasmic lipid bodies during hypoxia. Am. J. Physiol. Heart Circ. Physiol. 2001;280:H294–H301
  95. Yu W, Cassara J, Weller PF. Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood. 2000;95:1078–1085
  96. Pol A, Luetterforst R, Lindsay M, Heino S, Ikonen E, Parton RG. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J. Cell. Biol. 2001;152:1057–1070
  97. Fujimoto T, Kogo H, Ishiguro K, Tauchi K, Nomura R. Caveolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J. Cell. Biol. 2001;152:1079–1085
  98. Chen JS, Greenberg AS, Wang SM. Oleic acid-induced PKC isozyme translocation in RAW 264.7 macrophages. J. Cell. Biochem. 2002;86:784–791
  99. Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes. 2004;53:1261–1270
  100. Sato S, Fukasawa M, Yamakawa Y, Natsume T, Suzuki T, Shoji I, et al. Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 2006;139:921–930
  101. Fernandez MA, Albor C, Ingelmo-Torres M, Nixon SJ, Ferguson C, Kurzchalia T, et al. Caveolin-1 is essential for liver regeneration. Science. 2006;313:1628–1632
  102. Kurat CF, Wolinski H, Petschnigg J, Kaluarachchi S, Andrews B, Natter K, et al. Cdk1/Cdc28-dependent activation of the major triacylglycerol lipase Tgl4 in yeast links lipolysis to cell-cycle progression. Mol. Cell. 2009;33:53–63
  103. Yao M, Tabuchi H, Nagashima Y, Baba M, Nakaigawa N, Ishiguro H, et al. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J. Pathol. 2005;205:377–387
  104. Yao M, Huang Y, Shioi K, Hattori K, Murakami T, Nakaigawa N, et al. Expression of adipose differentiation-related protein: a predictor of cancer-specific survival in clear cell renal carcinoma. Clin. Cancer Res. 2007;13:152–160
  105. Bozza PT, Pacheco P, Yu W, Weller PF. NS-398: cyclooxygenase-2 independent inhibition of leukocyte priming for lipid body formation and enhanced leukotriene generation. Prostaglandins Leukot. Essent. Fatty Acids. 2002;67:237–244
  106. Paul A, Chang BH, Li L, Yechoor VK, Chan L. Deficiency of adipose differentiation-related protein impairs foam cell formation and protects against atherosclerosis. Circ. Res. 2008;102:1492–1501
  107. Namatame I, Tomoda H, Ishibashi S, Omura S. Antiatherogenic activity of fungal beauveriolides, inhibitors of lipid droplet accumulation in macrophages. Proc. Natl. Acad. Sci. USA. 2004;101:737–742
  108. Bozza PT, D'Avila H, Almeida PE, Magalhaes KG, Molinaro R, Almeida CJ, et al. Lipid droplets in host–pathogen interactions. Clin. Lipidol. 2009;4:791–807
  109. Miyanari Y, Atsuzawa K, Usuda N, Watashi K, Hishiki T, Zayas M, et al. The lipid droplet is an important organelle for hepatitis C virus production. Nat. Cell. Biol. 2007;9:1089–1097
  110. Boulant S, Targett-Adams P, McLauchlan J. Disrupting the association of hepatitis C virus core protein with lipid droplets correlates with a loss in production of infectious virus. J. Gen. Virol. 2007;88:2204–2213
  111. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res. 1998;58:362–366
  112. Sheng H, Shao J, Washington MK, DuBois RN. Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J. Biol. Chem. 2001;276:18075–18081
  113. Tsujii M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell. 1995;83:493–501

PII: S0952-3278(10)00049-9

doi: 10.1016/j.plefa.2010.02.005

Prostaglandins, Leukotrienes and Essential Fatty Acids
Volume 82, Issue 4 , Pages 243-250 , April 2010

Article Tools

* Image Usage & Resolution